Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025
Current Oncology · 17.04.2026 · 33 (4) · 228
DOI: 10.3390/curroncol33040228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 17.04.2026. Verfasst von Arwa Ahmed und 32 weiteren Autor:innen. Beteiligte Einrichtung: The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amgen, Astellas, astrazeneca, BMS—Bristol-Myers Squibb, Daiichi-Sankyo, Eisai, Incyte, Ipsen, Merk, Novartis, Roche, Pfizer, Viatris, Takeda, Taiho.
Abstract (Originalsprache)
The Eastern Canadian Gastrointestinal Cancer Consensus Conference convened annually and was held in Fredericton, New Brunswick, from 18 to 20 September 2025. Attendees included experts in medical oncology, radiation oncology, nuclear medicine, and general practitioners in oncology (GPO) from across the eastern Canadian provinces who are engaged in the care and management of patients with gastrointestinal malignancies. The consensus statement resulting from this meeting addresses several key topics, including the management of early-stage gastroesophageal junction cancer, recent developments in molecular biomarkers and colorectal cancer treatments, secondary prevention strategies for colorectal cancer, and treatment of hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ottawa Hospital Cancer Centre, Ottawa, ON K1H 8L6, Canada.
- Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 3A7, Canada.
- Department of Medicine, Dalhousie University, Saint John, NB E2L 4L5, Canada.
- Algoma District Cancer Program, Sault Ste. Marie, ON P6B 0A8, Canada.
- Dr. Georges-L.-Dumond University Hospital Center, Moncton, NB E1C 2Z3, Canada.
- Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
ORCID-Profile: Arwa Ahmed, Stéphanie L Mercier, Ravi Ramjeesingh, Donald James Bastin, Amandeep S Taggar, Conrad Falkson, Gordon Emil Locke, Mustapha Tehfe, James Michael, Holly Campbell, Suneil Khanna, Shivani Dadwal
Förderung
- Amgen, Astellas, astrazeneca, BMS—Bristol-Myers Squibb, Daiichi-Sankyo, Eisai, Incyte, Ipsen, Merk, Novartis, Roche, Pfizer, Viatris, Takeda, Taiho
Zitieren
APA
Ahmed, A., Mercier, S. L., Ramjeesingh, R., Thompson, R., James Bastin, D., Spadafora, S., Megid, T. B. C., Djedovic, V., Taggar, A. S., Falkson, C., Farooq, A. R., Locke, G. E., Connors, S., Wang, H. Y., Tehfe, M., Aubin, F., Samimi, S., Michael, J., Campbell, H., …, & Asmis, T. R. (2026). Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025. Current Oncology, 33(4), 228. https://doi.org/10.3390/curroncol33040228
Vancouver
Ahmed A, Mercier SL, Ramjeesingh R, Thompson R, James Bastin D, Spadafora S, et al. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025. Current Oncology. 2026;33(4):228. doi:10.3390/curroncol33040228
BibTeX
@article{Ahmed2026,
author = {Ahmed, Arwa and Mercier, Stéphanie L and Ramjeesingh, Ravi and Thompson, Robert and James Bastin, Donald and Spadafora, Silvana and Megid, Thais Baccili Cury and Djedovic, Vladimir and Taggar, Amandeep S and Falkson, Conrad and Farooq, Abdul Rehman and Locke, Gordon Emil and Connors, Stacie and Wang, Hao Yu and Tehfe, Mustapha and Aubin, Francine and Samimi, Setareh and Michael, James and Campbell, Holly and St-Hilaire, Eve and Khanna, Suneil and Saud Ali Al Darai, Mohammed and Whitlock, Pierre and Hyde, Angela and Galvis, Luisa and Saltiel, Marie-Philippe and Bailey, Adrian and Itani, Doha and Goel, Rakesh and Aldarmaki, Wadima and Dadwal, Shivani and Goodwin, Rachel and Asmis, Timothy R},
title = {Eastern Canadian Gastrointestinal Cancer Consensus Conference 2025},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {4},
pages = {228},
doi = {10.3390/curroncol33040228}
}
EUVIMED